Item Details

Print View

Conflict of Interest, Protection of Public Ownership, in Drug Development Deals Between Tax-Exempt, Federally Supported Labs and the Pharmaceutical Industry [electronic resource]: Hearing Before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, First Session

United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology
Format
Online; EBook; Government Document
Published
Washington : U.S. G.P.O., 1993.
Language
English
Series
ProQuest U.S. Congressional Hearings Digital Collection
SuDoc Number
Y 4.SM 1:103-5
Description
v. : ill. ; 24 cm.
System requirements: PDF reader software.
Notes
  • Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection (last viewed Nov. 2009) Reuse except for individual research requires license from ProQuest, LLC.
  • Access to the Congressional Hearings Digital Collection is restricted by license to users on UVA's network. This document may also be available in print or microform at either UVa's Alderman or Law Libraries.
  • CIS No. HRG-1993-SMB-0028
  • CIS No. HRG-1993-SMB-0016
  • CIS No. HRG-1993-SMB-0004
  • Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection. Reuse except for individual research requires license from ProQuest, LLC.
Reproduction Notes
Electronic reproduction. [Bethesda, Md.] : ProQuest, 2004. digital, PDF file. ProQuest U.S. Congressional Hearings Digital Collection. Mode of access: World Wide Web via ProQuest website.
Copyright Not EvaluatedCopyright Not Evaluated
Technical Details
  • Staff View

    LEADER 03805nam a22004451a 4500
    001 cis2007462313
    006 m d f
    007 cr bn mmmapmmp
    008 091022s1993 dcua s f000 0 eng d
    043
      
      
    a| n-us---
    074
      
      
    a| 1031-A, 1031-B (Microfiche)
    086
    0
      
    a| Y 4.SM 1:103-5
    110
    1
      
    a| United States. b| Congress. b| House. b| Committee on Small Business. b| Subcommittee on Regulation, Business Opportunities, and Technology.
    245
    1
    0
    a| Conflict of interest, protection of public ownership, in drug development deals between tax-exempt, federally supported labs and the pharmaceutical industry h| [electronic resource] : b| hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session.
    260
      
      
    a| Washington : b| U.S. G.P.O., c| 1993.
    300
      
      
    a| v. : b| ill. ; c| 24 cm.
    500
      
      
    a| Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection (last viewed Nov. 2009) Reuse except for individual research requires license from ProQuest, LLC.
    500
      
      
    a| Access to the Congressional Hearings Digital Collection is restricted by license to users on UVA's network. This document may also be available in print or microform at either UVa's Alderman or Law Libraries.
    500
      
      
    a| CIS No. HRG-1993-SMB-0028
    500
      
      
    a| CIS No. HRG-1993-SMB-0016
    500
      
      
    a| CIS No. HRG-1993-SMB-0004
    500
      
      
    a| Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection. Reuse except for individual research requires license from ProQuest, LLC.
    533
      
      
    a| Electronic reproduction. b| [Bethesda, Md.] : c| ProQuest, d| 2004. e| digital, PDF file. n| ProQuest U.S. Congressional Hearings Digital Collection. n| Mode of access: World Wide Web via ProQuest website.
    538
      
      
    a| System requirements: PDF reader software.
    650
      
    0
    a| Drugs x| Research x| Government policy z| United States.
    650
      
    0
    a| Drugs z| United States v| Patents.
    650
      
    0
    a| Research and development contracts, Government z| United States.
    650
      
    0
    a| Pharmaceutical industry x| Government policy z| United States.
    650
      
    0
    a| Conflict of interests z| United States.
    650
      
    0
    a| Norgestrel x| Prices z| United States.
    650
      
    0
    a| Contraceptives x| Prices z| United States.
    650
      
    0
    a| Research and development partnership z| United States.
    776
    0
    8
    i| Print version: a| United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology t| Conflict of interest, protection of public ownership, in drug development deals between tax-exempt, federally supported labs and the pharmaceutical industry w| gp 93087758 w| (OCoLC)28658789
    776
    0
    8
    i| Microfiche version: a| United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology t| Conflict of interest, protection of public ownership, in drug development deals between tax-exempt, federally supported labs and the pharmaceutical industry. d| [Bethesda, Md.] : ProQuest,[2004] o| CIS 93 H721-22 (pt.1) o| CIS 93 H721-34 (pt.2) o| CIS 94 H721-20 (pt.3) w| (ProQuest)cis09301382
    830
      
    0
    a| ProQuest U.S. Congressional Hearings Digital Collection.
    856
    4
    0
    u| http://proxy.its.virginia.edu/login?url=http://congressional.proquest.com/congcomp/getdoc?HEARING-ID=HRG-1993-SMB-0004 y| Electronic resource (PDF)
    856
    4
    0
    u| http://proxy.its.virginia.edu/login?url=http://congressional.proquest.com/congcomp/getdoc?HEARING-ID=HRG-1993-SMB-0016 y| Electronic resource (PDF)
    856
    4
    0
    u| http://proxy.its.virginia.edu/login?url=http://congressional.proquest.com/congcomp/getdoc?HEARING-ID=HRG-1993-SMB-0028 y| Electronic resource (PDF)
    998
      
      
    a| cis09301382
    040
      
      
    a| UMI c| UMI
▾See more
▴See less

Availability